123 related articles for article (PubMed ID: 16618886)
1. Treatment of precancerous and cancerous lesions of chronic arsenicism with 5% imiquimod cream.
Boonchai W
Arch Dermatol; 2006 Apr; 142(4):531-2. PubMed ID: 16618886
[No Abstract] [Full Text] [Related]
2. Imiquimod cream 5% for the treatment of arsenic-induced cutaneous neoplasms.
Lonergan CL; McNamara EK; Cordoro KM; Greer KE
Cutis; 2010 Apr; 85(4):199-202. PubMed ID: 20486460
[TBL] [Abstract][Full Text] [Related]
3. Topical imiquimod to treat intraepidermal carcinoma.
Hengge UR; Stark R
Arch Dermatol; 2001 Jun; 137(6):709-11. PubMed ID: 11405756
[No Abstract] [Full Text] [Related]
4. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Tutrone WD; Saini R; Caglar S; Weinberg JM; Crespo J
Cutis; 2003 May; 71(5):365-70. PubMed ID: 12769403
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases.
Stockfleth E; Meyer T; Benninghoff B; Christophers E
Br J Dermatol; 2001 May; 144(5):1050-3. PubMed ID: 11359396
[TBL] [Abstract][Full Text] [Related]
6. Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the head.
Stockfleth E; Sterry W; Carey-Yard M; Bichel J
Br J Dermatol; 2007 Dec; 157 Suppl 2():41-6. PubMed ID: 18067631
[TBL] [Abstract][Full Text] [Related]
7. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.
Korman N; Moy R; Ling M; Matheson R; Smith S; McKane S; Lee JH
Arch Dermatol; 2005 Apr; 141(4):467-73. PubMed ID: 15837864
[TBL] [Abstract][Full Text] [Related]
8. New therapy update: ALDARA (imiquimod cream, 5%).
Abramovits W; Gupta AK
Skinmed; 2004; 3(4):215. PubMed ID: 15249782
[No Abstract] [Full Text] [Related]
9. Successful treatment of keratoacanthoma and actinic keratoses with imiquimod 5% cream.
Peris K; Micantonio T; Fargnoli MC
Eur J Dermatol; 2003; 13(4):413-4; author reply 415. PubMed ID: 12948930
[No Abstract] [Full Text] [Related]
10. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis.
Kose O; Koc E; Erbil AH; Caliskan E; Kurumlu Z
J Dermatolog Treat; 2008; 19(3):159-63. PubMed ID: 18569272
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
McGillis ST; Fein H
Semin Cutan Med Surg; 2004 Sep; 23(3):174-83. PubMed ID: 15584683
[TBL] [Abstract][Full Text] [Related]
12. [Multiple bowenoid arsenic keratoses].
Leyh F; Rothlaender JP
Derm Beruf Umwelt; 1985; 33(3):99-101. PubMed ID: 4028974
[TBL] [Abstract][Full Text] [Related]
13. Imiquimod and lymphatic field clearance: a new hypothesis based on a remote immune action on skin cancer.
Akkilic-Materna M; Massone C; Komericki P
Acta Derm Venereol; 2011 Jun; 91(4):432-5. PubMed ID: 21547348
[TBL] [Abstract][Full Text] [Related]
14. Skin cancer induced by arsenic in the water.
Cabrera HN; Gómez ML
J Cutan Med Surg; 2003; 7(2):106-11. PubMed ID: 12447618
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of multiple actinic keratoses in organ transplant patients with topical 5% imiquimod: a report of six cases.
Ulrich C; Busch JO; Meyer T; Nindl I; Schmook T; Sterry W; Stockfleth E
Br J Dermatol; 2006 Aug; 155(2):451-4. PubMed ID: 16882188
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of 5% imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients: randomized, double-blind, placebo-controlled trial.
Brown VL; Atkins CL; Ghali L; Cerio R; Harwood CA; Proby CM
Arch Dermatol; 2005 Aug; 141(8):985-93. PubMed ID: 16103328
[TBL] [Abstract][Full Text] [Related]
17. Levels of arsenic in drinking-water and cutaneous lesions in Inner Mongolia.
Guo X; Liu Z; Huang C; You L
J Health Popul Nutr; 2006 Jun; 24(2):214-20. PubMed ID: 17195562
[TBL] [Abstract][Full Text] [Related]
18. Effect of dosing frequency on the safety and efficacy of imiquimod 5% cream for treatment of actinic keratosis on the forearms and hands: a phase II, randomized placebo-controlled trial.
Gebauer K; Shumack S; Cowen PS
Br J Dermatol; 2009 Oct; 161(4):897-903. PubMed ID: 19545297
[TBL] [Abstract][Full Text] [Related]
19. Imiquimod 5 percent cream and the treatment of cutaneous malignancy.
Navi D; Huntley A
Dermatol Online J; 2004 Jul; 10(1):4. PubMed ID: 15347486
[TBL] [Abstract][Full Text] [Related]
20. Imiquimod 5% cream in the treatment of mycosis fungoides--a pilot study.
Chong A; Loo WJ; Banney L; Grant JW; Norris PG
J Dermatolog Treat; 2004 Apr; 15(2):118-9. PubMed ID: 15204164
[No Abstract] [Full Text] [Related]
[Next] [New Search]
